Whitepaper: Risk-Based Quality Management (RBQM)
📄 About This Document
Learn how Risk-Based Quality Management (RBQM) can enhance the quality, efficiency, and oversight of clinical trials. This one-pager outlines the key principles of RBQM, its core components, and insights from a case study on SDV in neurodegenerative studies.
📥 Download the full document to explore how RBQM strategies can optimize your clinical projects.
Related
Case Study: Accelerating Performance in a Phase III CVOT Rescue Program for a Mid-Size Biotech
Rescuing a Stalled Cardiovascular Outcomes Trial Through Targeted Operational Intervention When a Phase III cardiovascular outcomes trial (CVOT) faced significant enrollment delays and timeline risk, Julius Clinical was engaged to support and acc...
Case Study: Supporting Global Delivery of a Phase III Cardiovascular Outcomes Trial for a Global Top-10 Pharmaceutical Company
Executing a Complex Phase III Diabetes Cardiovascular Outcomes Trial in a High-Risk Population Cardiovascular outcomes trials (CVOTs) in type 2 diabetes present a unique combination of clinical, operational, and regulatory complexity, particularl...
Epilepsy Foundation Pipeline Conference 2026
Join Julius Clinical at the Epilepsy Foundation Pipeline Conference in Leesburg, Virginia from June 18-19, 2026. Meet our neuroscience experts at the Epilepsy Foundation Pipeline Conference 2026 to discover how Julius Clinical supports efficient,...
